Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.
3.

Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin.

Medhurst AD, Jennings CA, Robbins MJ, Davis RP, Ellis C, Winborn KY, Lawrie KW, Hervieu G, Riley G, Bolaky JE, Herrity NC, Murdock P, Darker JG.

J Neurochem. 2003 Mar;84(5):1162-72.

4.

Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure.

Földes G, Horkay F, Szokodi I, Vuolteenaho O, Ilves M, Lindstedt KA, Mäyränpää M, Sármán B, Seres L, Skoumal R, Lakó-Futó Z, deChâtel R, Ruskoaho H, Tóth M.

Biochem Biophys Res Commun. 2003 Aug 29;308(3):480-5.

PMID:
12914775
5.

Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility.

Szokodi I, Tavi P, Földes G, Voutilainen-Myllylä S, Ilves M, Tokola H, Pikkarainen S, Piuhola J, Rysä J, Tóth M, Ruskoaho H.

Circ Res. 2002 Sep 6;91(5):434-40.

6.

Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system.

Katugampola SD, Maguire JJ, Kuc RE, Wiley KE, Davenport AP.

Can J Physiol Pharmacol. 2002 May;80(5):369-74. Review.

PMID:
12056541
7.

Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin.

Hosoya M, Kawamata Y, Fukusumi S, Fujii R, Habata Y, Hinuma S, Kitada C, Honda S, Kurokawa T, Onda H, Nishimura O, Fujino M.

J Biol Chem. 2000 Jul 14;275(28):21061-7.

8.

Pharmacological characterization and autoradiographic localization of a putative dopamine D4 receptor in the heart.

Ricci A, Bronzetti E, Fedele F, Ferrante F, Zaccheo D, Amenta F.

J Auton Pharmacol. 1998 Apr;18(2):115-21.

PMID:
9730266
10.

Characterization of apelin, the ligand for the APJ receptor.

Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, Osmond DH, George SR, O'Dowd BF.

J Neurochem. 2000 Jan;74(1):34-41.

11.
12.

Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJ.

Fan X, Zhou N, Zhang X, Mukhtar M, Lu Z, Fang J, DuBois GC, Pomerantz RJ.

Biochemistry. 2003 Sep 2;42(34):10163-8.

PMID:
12939143
13.

Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor.

Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C, Kurokawa T, Onda H, Fujino M.

Biochem Biophys Res Commun. 1998 Oct 20;251(2):471-6.

PMID:
9792798
14.

Immunohistochemical study of apelin, the natural ligand of receptor APJ, in a case of AIDS-related cachexia.

Esposito V, De Falco M, De Luca L, Acanfora F, Onori N, Loiacono L, Montesarchio V, Rossi M, De Luca B, Chirianni A.

In Vivo. 2002 Sep-Oct;16(5):337-40.

PMID:
12494874
15.
16.

Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase.

Kleinz MJ, Baxter GF.

Regul Pept. 2008 Feb 7;146(1-3):271-7. Epub 2007 Oct 22.

PMID:
18022257
17.

Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure.

El Messari S, Iturrioz X, Fassot C, De Mota N, Roesch D, Llorens-Cortes C.

J Neurochem. 2004 Sep;90(6):1290-301.

18.

Emerging roles of apelin in biology and medicine.

Kleinz MJ, Davenport AP.

Pharmacol Ther. 2005 Aug;107(2):198-211. Review.

PMID:
15907343
19.

Apelin peptides block the entry of human immunodeficiency virus (HIV).

Zou MX, Liu HY, Haraguchi Y, Soda Y, Tatemoto K, Hoshino H.

FEBS Lett. 2000 May 4;473(1):15-8.

20.

Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain.

Reaux A, De Mota N, Skultetyova I, Lenkei Z, El Messari S, Gallatz K, Corvol P, Palkovits M, Llorens-Cortès C.

J Neurochem. 2001 May;77(4):1085-96.

Supplemental Content

Support Center